Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy.

Saved in:
Bibliographic Details
Title: Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy.
Authors: Honma O; Department of Nursing, Showa University Hospital, Tokyo, Japan.; Department of Nursing, Showa University School of Nursing and Rehabilitation Sciences, Kanagawa, Japan., Watanabe C; Department of Nursing, Showa University School of Nursing and Rehabilitation Sciences, Kanagawa, Japan., Fukuchimoto H; Department of Nursing, Showa University School of Nursing and Rehabilitation Sciences, Kanagawa, Japan.; Department of Nursing, Showa University Koto Toyosu Hospital, Tokyo, Japan., Kashiwazaki J; Faculty of Nursing, Kyoritsu Women's University, Tokyo, Japan., Tateba M; Department of Nursing, Showa University Hospital, Tokyo, Japan.; Department of Nursing, Showa University School of Nursing and Rehabilitation Sciences, Kanagawa, Japan., Wagatsuma S; Department of Nursing, Showa University Hospital, Tokyo, Japan.; Department of Nursing, Showa University School of Nursing and Rehabilitation Sciences, Kanagawa, Japan., Ogata K; Department of Nursing, Showa University Hospital, Tokyo, Japan., Maki K; Department of Nursing, Showa University Hospital, Tokyo, Japan., Sonou H; Department of Nursing, Showa University Hospital, Tokyo, Japan., Shiga K; Department of Nursing, Showa University Koto Toyosu Hospital, Tokyo, Japan., Otsuka E; Department of Nursing, Showa University Hospital, Tokyo, Japan., Hiruta M; Department of Nursing, Showa University Hospital, Tokyo, Japan., Hirasawa Y; Department of Medical Oncology, Showa University, Tokyo, Japan., Hosonuma M; Department of Clinical Immunology and Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Murayama M; Department of Clinical Immunology and Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Narikawa Y; Department of Clinical Immunology and Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Toyoda H; Department of Clinical Immunology and Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Tsurui T; Department of Medical Oncology, Showa University, Tokyo, Japan., Kuramasu A; Department of Clinical Immunology and Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Kin M; Department of Pharmacy, Showa University Hospital, Tokyo, Japan., Kubota Y; Department of Medical Oncology, Showa University, Tokyo, Japan., Sambe T; Division of Clinical Pharmacology, Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Japan., Horiike A; Department of Medical Oncology, Showa University, Tokyo, Japan., Ishida H; Division of Medical Oncology, Showa University Northern Yokohama Hospital, Yokohama, Japan., Shimada K; Division of Medical Oncology, Internal Medicine Center, Showa University Koto Toyosu Hospital, Tokyo, Japan., Umeda M; Family Hospice Co., Ltd., Tokyo, Japan., Tsunoda T; Department of Medical Oncology, Showa University, Tokyo, Japan., Yoshimura K; Department of Clinical Immunology and Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.
Source: Frontiers in pharmacology [Front Pharmacol] 2022 Feb 09; Vol. 13, pp. 744916. Date of Electronic Publication: 2022 Feb 09 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1663-9812
DOI:10.3389/fphar.2022.744916